Recent EW News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:13:52 PM
- Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits • Business Wire • 03/30/2026 02:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/26/2026 08:07:42 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/26/2026 08:07:14 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/26/2026 08:06:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/26/2026 08:05:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2026 09:10:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 08:02:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 10:50:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 12:33:53 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2026 09:08:19 PM
- Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose • Business Wire • 02/26/2026 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 10:08:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2026 10:08:49 PM
- Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences • Business Wire • 02/19/2026 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:16:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:16:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 10:37:29 PM
- Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day • Business Wire • 02/13/2026 12:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/12/2026 09:54:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 09:22:48 PM
- Edwards Lifesciences Reports Fourth Quarter Results • Business Wire • 02/10/2026 09:15:00 PM
- Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026 • Business Wire • 02/03/2026 12:05:00 PM
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference • Business Wire • 02/02/2026 12:05:00 PM
- AI Diagnostics: The End of the High-Cost Imaging Era • GlobeNewswire Inc. • 01/16/2026 04:40:51 PM
